E-grāmata: Silver Nanoparticles for Drug Delivery

Part A. Synthesis and characterization of silver nanoparticles for drug delivery 1. History, introduction, and physicochemical properties of silver nanoparticles
2. Synthesis methods and characterization parameters of silver nanoparticles
3. Green synthesis/ biosynthesis of silver nanoparticles and plant disease management
4. Biofate and cellular interactions of silver nanoparticles

Part B. Application of silver nanoparticles in drug delivery
5. Targeting strategies and clinical implications of bio-conjugated silver nanoparticles in drug delivery
6. Silver nanoparticles for cancer diagnosis and treatment of cancer
7. Silver nanoparticles for targeted tumor imaging and enhanced photodynamic therapy
8. Silver nanoparticles against multi-drug resistant bacteria and bacterial biofilms
9. Silver nanoparticles in wound therapy and tissue regeneration
10. Silver nanoparticles for treatment of inflammatory diseases
11. Silver nanoparticles for treatment of diabetes
12. Silver nanoparticles for treatment of neurodegenerative disorder
13. Silver nanoparticles in dentistry
14. Silver nanoparticles for treatment of COVID-19 and other viral diseases

Part C. Recent advances and regulatory aspects of silver nanoparticles
15. Coated/Hybrid silver nanoparticles as advanced drug delivery and theranostics application
16. Biological toxicity, safety issues and environmental hazards associated with silver nanoparticles
17. Silver nanoparticles-induced ecotoxicity
18. Clinical translation of silver nanoparticles into market
19. Conclusion and future prospective of silver nanoparticles

Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 350 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as USERN Laureate award”, most prestigious SERB-Ramanujan Fellowship Award”. He actively participates in outreach and scientific dissemination for the service of the wider community. His Number of citations is = 26779; h-index = 85; i-10 index = 370 (According to google scholar on March 2025). He has more than 30 international publications published in very high impact factor journals (Progress in Polymer Sciences IF 32.063, Molecular Sciences IF 41.444, Progress in Material Sciences IF 48.580, Advanced Materials IF 29.4, Drug Resistance Update IF 22.841 and Material Todays IF 32.072). He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of the wider community.